Nitric oxide signalling in salivary glands

Journal of Oral Pathology and Medicine

Volumn 31, Issue 10, 2002, Pages 569-584

  Looms, Dagnia ^a   Tritsaris, Katerina ^a   Pedersen, Anne Marie ^a   Nauntofte, Birgitte ^a   Dissing, Steen ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

adrenergic receptor; cGMP; DAF 2; G kinase; Intra cellular Ca2+; Nitric oxide; Salivary gland; Secretion

Indexed keywords

CALCIUM; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL; BIOSYNTHESIS; CALCIUM SIGNALING; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; SALIVA; SALIVARY GLAND; SECRETION; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME;

ANIMALS; CALCIUM; CALCIUM SIGNALING; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; HOMEOSTASIS; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SALIVA; SALIVARY GLANDS; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME;

EID: 0036847160     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0714.2002.00047.x     Document Type: Review

References (125)

1. Palmer RMJ, Ferridge AG, Moncada S. Nitric oxide accounts for the biological activity of endothelial-derived relaxing factor. Nature 1987; 327: 524-6.
2. Michel T, Feron O. Nitric oxide synthases which: Where, how, and why? J Clin Invest 1997; 100: 2146-52.
3. Stuehr DJ. Mammalian nitric oxide synthases. Biochim Biophys Acta 1999; 1411: 217-30.
4. Schmidt HHHW, Lohmann SM, Walter U. The nitric oxide and cGMP signal transduction system: Regulation and mechanism of action. Biochim Biophys Acta 1993; 1178: 153-75.
5. Stoyanovsky D, Murphy T, Anno PR, Kim Y-M, Salama G. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 1997; 21: 19-29.
6. 3 receptors in sublingual glands. Am J Physiol Cell Physiol 2001; 280: C884-96.
7. Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 1984; 312: 315-21.
8. 2+ release in sea urchin egg homogenates: Modulation by cyclic ADP-ribose. Science 1991; 253: 1143-6
9. Glenert U, Nauntofte B. Stimulation-induced changes in cyclic nucleotide content by isolated rat parotid acini: Effects of calcium. Pharmacol Toxicol 1988; 62: 282-9.
10. Alm P, Ekström J, Larsson B, Tobin G, Andersson K-E. Nitric oxide synthase immunoreactive nerves in rat and ferret salivary glands, and effects of denervation. Histochem J 1997; 29: 669-76.
11. Lohinai Z, Székely AD, Soós L, Fehér E. Distribution of nitric oxide synthase containing elements in the feline submandibular gland. Neurosci Lett 1995; 192: 9-12.
12. Soinila S, Vanhatalo S, Lumme A, Bäck N, Soinila J. Nitric oxide synthase in the autonomic and sensory ganglia innervating the submandibular salivary gland. Microsc Res Techn 1996; 35: 32-43.
13. Takai N, Uchihashi K, Higuchi K, Yoshida Y, Yamaguchi M. Localization of neuronal-constitutive nitric oxide synthase and secretory regulation by nitric oxide in the rat submandibular and sublingual glands. Arch Oral Biol 1999; 44: 745-50.
14. 2+ signalling in labial salivary glands of healthy individuals and patients with primary Sjögren's syndrome (pSS). J Oral Pathol Med 2000; 29: 97-109.
15. Cheng S-B, Kuchiiwa S, Kuchiiwa T, Nonaka S, Nakagawa S. Presence of neuronal nitric oxide synthase in autonomic and sensory ganglion neurons innervating the lacrimal glands of the cat: An immunofluorescent and retrograde tracer double-labeling study. J Chem Neuroanat 2001; 22: 147-55.
16. 2+ influx in rat pancreatic acinar and submandibular salivary gland cells. Cell Calcium 1997; 22: 217-28.
17. 2+ release in rat parotid acinar cells. Pflügers Arch 2000; 440: 223-8.
18. Looms DK, Dissing S, Tritsaris K, Pedersen AM, Nauntofte B. Adrenoceptor-activated nitric oxide synthesis in salivary acinar cells. Adv Dent Res 2000; 14: 62-8.
19. Looms DK, Tritsaris K, Dissing S. Nitric oxide-induced signalling in rat lacrimal acinar cells. Acta Physiol Scand 2002; 274: 109-15.
20. 2+-regulated nitric oxide generation in rabbit parotid acinar cells. Cell Calcium 2001; 30: 107-16.
21. Mitsui Y, Furuyama S. Characterization of nitric oxide synthase in the rat parotid gland. Arch Oral Biol 2000; 45: 531-6.
22. Kojima H, Nakatsubo N, Kikuchi K, et al. Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal Chem 1998; 70: 2446-53.
23. Kimber J, Mitchell D, Mathias CJ. Chronic cough in the Holmes-Adie syndrome: Association in five cases with autonomic dysfunction. J Neurol Neurosurg Psychiatry 1998; 65: 583-6.
24. Broillet M-C, Randin O, Chatton J-Y. Photoactivation and calcium sensitivity of the fluorescent NO indicator 4,5-diaminofluorescein (DAF-2): Implications for cellular NO imaging. FEBS Lett 2001; 491: 227-32.
25. Genaro AM, Stranieri GM, Borda E. Involvement of the endogenous nitric oxide signalling system in bradykinin receptor activation in rat submandibular salivary gland. Arch Oral Biol 2000; 45: 723-9.
26. Bredt DS, Ferris CD, Snyder SH. Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP-dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase: Identification of flavin and calmodulin binding sites. J Biol Chem 1992; 267: 10976-81.
27. 2+ release processes in rat parotid acinar cells. Biochem J 2001; 355: 87-95.
28. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one. Mol Pharmacol 1995; 48: 184-8.
29. 2+ release channels and their regulation by endogenous effectors. Annu Rev Physiol 1994; 56: 485-508.
30. 2+ pools in canine salivary gland cells. J Dent Res 1998; 77: 1807-16.
31. Masuda W, Noguchi T. ADP-ribosyl cyclase in rat salivary glands. Biochem Biophys Res Commun 2000; 270: 469-72.
32. 2+ release from microsomal vesicles of rat parotid acinar cells: Regulation by cyclic ADP-ribose. J Membr Biol 1997; 156: 231-9.
33. Willmott N, Sethi JK, Walseth TF, Lee HC, White AM, Galione A. Nitric oxide-induced mobilisation of intracellular calcium via the cyclic ADP-ribose pathway. J Biol Chem 1996; 271: 3699-705.
34. 2+ release from cyclic ADP-ribose-sensitive stores. J Neurophysiol 1999; 82: 1569-76.
35. Clementi E, Riccio M, Sciorati C, Nisticò G, Meldolesi J. The type 2 ryanodine receptor of neurosecretory PC12 cells is activated by cyclic ADP-ribose. J Biol Chem 1996; 271: 17739-45.
36. Lee HC. Modulator and messenger functions of cyclic ADP-ribose in calcium signalling. Recent Prog Horm Res 1996; 51: 355-89.
37. 2+ release in neurosecretory PC-12 cells: Inhibition of phospholipase C activity via cyclic GMP-dependent protein kinase I. Mol Pharmacol 1995; 47: 517-24.
38. i responses are negatively modulated via a cGMP-dependent protein kinase I pathway. J Biol Chem 1995; 270: 22277-82.
39. Nguyen BL, Saitoh M, Ware JA. Interaction of nitric oxide and cGMP with signal transduction in activated platelets. Am J Physiol 1991; 261: H1043-52.
40. Pfeifer A, Nürnberg B, Kamm S, et al. Cyclic GMP-dependent protein kinase blocks pertussis toxin-sensitive hormone receptor signaling pathways in Chinese hamster ovary cells. J Biol Chem 1995; 270: 9052-9.
41. Xia C, Bao Z, Yue C, Sanborn BM, Liu M. Phosphorylation and regulation of G-protein-activated phospholipase C-β 3 by cGMP-dependent protein kinases. J Biol Chem 2001; 276: 19770-7.
42. 2+ release in guinea-pig hepatocytes. Biochem J 1996; 318: 849-55.
43. Rooney TA, Joseph SK, Queen C, Thomas AP. Cyclic GMP induces oscillatory calcium signals in rat hepatocytes. J Biol Chem 1996; 271: 19817-25.
44. Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor by cyclic GMP-dependent protein kinase. J Biol Chem 1994; 269: 8701-7.
45. Cavallini L, Coassin M, Borean A, Alexandre A. Prostacyclin and sodium nitroprusside inhibit the activity of the platelet inositol 1,4,5-trisphosphate receptor and promote its phosphorylation. J Biol Chem 1996; 271: 5545-51.
46. Publicover NG, Hammond EM, Sanders KM. Amplification of nitric oxide signaling by interstitial cells isolated from canine colon. Proc Natl Acad Sci USA 1993; 90: 2087-91.
47. 2+ entry into colonic epithelial cells by NO and cGMP. Cell Calcium 1995; 17: 250-62.
48. 2+ influx. J Biol Chem 1994; 269: 12645-53.
49. Hölschermann H, Noll T, Hempel A, Piper HM. Dual role of cGMP in modulation of macromolecule permeability of aortic endothelial cells. Am J Physiol 1997; 272: H91-8.
50. 2+ entry in human platelets. Biochem J 1995; 310: 263-9.
51. 2+ current is regulated by cyclic GMP-dependent protein kinase in mammalian cardiac myocytes. Proc Natl Acad Sci USA 1991; 88: 1197-201.
52. 2+ in lacrimal acinar cells by α, β-adrenergic and muscarinic cholinergic stimulation: The roles of inositol trisphosphate and cyclic ADP-ribose. Pflügers Arch 1995; 429: 751-61.
53. Looms DK, Tritsaris K, Dissing S, et al. Regulation of salivary secretion: Interactions between signalling pathways. In: Guggenheim B Shapiro S, eds. Oral Biology at the Turn of the Century: Misconceptions, Truths and Prospects. Basel, Switzerland: Karger, 1998; 179-88.
54. 2+ response in rat parotid cells. Am J Physiol 1999; 276: C1282-7.
55. Mckinney JS, Desole MS, Rubin RP. Convergence of cAMP and phosphoinositide pathways during rat parotid secretion. Am J Physiol 1989; 257: C651-7.
56. Rubin RP, Adolf MA. Cyclic AMP regulation of calcium mobilization and amylase release from isolated permeabilized rat parotid cells. J Pharmacol Exp Ther 1994; 268: 600-6.
57. Nauntofte B, Dissing S. Stimulation-induced changes in cytosolic calcium in rat parotid acini. Am J Physiol 1987; 253: G290-7.
58. 2+ mobilization and inositol trisphosphate formation in parotid acinar cells? Cell Calcium 1989; 10: 519-25.
59. 2+ distribution in rat parotid acinar cells. Eur J Pharmacol 1998; 360: 73-9.
60. Edwards AV, Tobin G, Ekström J, Bloom SR. Nitric oxide and release of the peptide VIP from parasympathetic terminals in the submandibular gland of the anaesthetized cat. Exp Physiol 1996; 81: 349-59.
61. Tobin G, Edwards AV, Bloom SR, Ekström J. Nitric oxide in the control of submandibular salivary gland function in the anaesthetized ferret. Exp Physiol 1997; 82: 825-36.
62. Hanna SJ, Edwards AV. The role of nitric oxide in the control of protein secretion in the parotid gland of anaesthetized sheep. Exp Physiol 1998; 83: 533-44.
63. Buckle AD, Parker SJ, Bloom SR, Edwards AV. The role of nitric oxide in the control of protein secretion in the submandibular gland of the cat. Exp Physiol 1995; 80: 1019-30.
64. Turner JT, Camden JM. The influence of vasoactive intestinal peptide receptors in dispersed acini from rat submandibular gland on cyclic AMP production and mucin release. Arch Oral Biol 1990; 35: 103-8.
65. Dartt DA, Baker AK, Vaillant C, Rose PE. Vasoactive intestinal polypeptide stimulation of protein secretion from rat lacrimal gland acini. Am J Physiol 1984; 247: G502-9.
66. Lundberg JM, Änggård A, Fahrenkrug J, Hökfelt T, Mutt V. Vasoactive intestinal polypeptide in cholinergic neurons of exocrine glands: Functional significance of coexisting transmitters for vasodilation and secretion. Proc Natl Acad Sci USA 1980; 77: 1651-5.
67. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-5.
68. Fulton D, Gratton J-P, Mccabe TJ, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999; 399: 597-601.
69. Butt E, Bernhardt M, Smolenski A, et al. Endothelial nitric oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 2000; 275: 5179-87.
70. Mccabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain 'calcium-independent' eNOS activation by phosphorylation. J Biol Chem 2000; 275: 6123-8.
71. Chen Z-P, Mitchelhill KI, Michell BJ, et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 1999; 443: 285-9.
72. Harris MB, Ju H, Venema VJ, et al. Reciprocal phosphorylation and regulation of endothelial nitric oxide synthase in response to bradykinin stimulation. J Biol Chem 2001; 276: 16587-91.
73. Michell BJ, Chen Z-P, Tiganis T, et al. Coordinated control of endothelial nitric oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 2001; 276: 17625-8.
74. Salerno JC, Harris DE, Irizarry K, et al. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J Biol Chem 1997; 272: 29769-77.
75. 2+-calmodulin. Biochemistry 1996; 35: 14651-8.
76. Michel T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993; 90: 6252-6.
77. Marrero MB, Venema VJ, Ju H, et al. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J 1999; 343: 335-40.
78. Dawson TM, Steiner JP, Dawson VL, Dinerman JL, Uhl GR, Snyder SH. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 9808-12.
79. Dinerman JL, Steiner JP, Dawson TM, Dawson V, Snyder SH. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology 1994; 33: 1245-51.
80. Hayashi Y, Nishio M, Naito Y, et al. Regulation of neuronal nitric oxide synthase by calmodulin kinases. J Biol Chem 1999; 274: 20597-602.
81. Hecker M, Mülsch A, Busse R. Subcellular localization and characterization of neuronal nitric oxide synthase. J Neurochem 1994; 62: 1524-9.
82. Cordelier P, Esteve J-P, Rivard N, et al. The activation of neuronal NO synthase is mediated by G-protein βγ subunit and the tyrosine phosphatase SHP-2. FASEB J 1999; 13: 2037-50.
83. Liu R, Flammer J, Haefliger IO. Isoproterenol, forskolin, and cAMP-induced nitric oxide production in pig ciliary processes. Invest Ophthalmol Vis Sci 1999; 40: 1833-7.
84. 2+. Cell Calcium 1993; 14: 711-23.
85. Ignarro LJ. Signal transduction mechanisms involving nitric oxide. Biochem Pharmacol 1991; 41: 485-90.
86. Anderson LC, Garrett JR. Neural regulation of blood flow in the rat submandibular gland. Eur J Morphol 1998; 36: 213-8.
87. Snyder SH. Nitric oxide: First in a new class of neurotransmitters? Science 1992; 257: 494-6.
88. Gage AT, Reyes M, Stanton PK. Nitric oxide-guanylyl-cyclase-dependent and -independent components of multiple forms of long-term synaptic depression. Hippocampus 1997; 7: 286-95.
89. 2+-independent synaptic vesicle release. Neuron 1994; 12: 1235-44.
90. Yamazaki M, Chiba K, Mohri T, Hatanaka H. Activation of the mitogen-activated protein kinase cascade through nitric oxide synthesis as a mechanism of neuritogenic effect of genipin in PC12h cells. J Neurochem 2001; 79: 45-54.
91. Jozkowicz A, Cooke JP, Guevara I, et al. Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF. Cardiovasc Res 2001; 51: 773-83.
92. Benoit H, Jordan M, Wagner H, Wagner PD. Effect of NO, vasodilator prostaglandins, and adenosine on skeletal muscle angiogenic growth factor gene expression. J Appl Physiol 1999; 86: 1513-8.
93. Papapetropoulos A, García-Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 1997; 100: 3131-9.
94. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-34.
95. Bodis S, Haregewoin A. Evidence for the release and possible neural regulation of nitric oxide in human saliva. Biochem Biophys Res Commun 1993; 194: 347-50.
96. Whittle BJR. Nitric oxide in physiology and pathology. Histochem J 1995; 27: 727-37.
97. Brennan PA, Downie IP, Langdon JD, Zaki GA. Emerging role of nitric oxide in cancer. Br J Oral Maxillofac Surg 1999; 37: 370-3.
98. Kendall HK, Marshall RI, Bartold PM. Nitric oxide and tissue destruction. Oral Dis 2001; 7: 2-10.
99. Strand V, Talal N. Advances in the diagnosis and concept of Sjõgren's syndrome (autoimmune exocrinopathy). Bull Rheum Dis 1980; 30: 1046-50.
100. Pedersen AM, Nauntofte B. Primary Sjögren's syndrome: Oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy. Expert Opin Pharmacother 2001; 2: 1-22.
101. Robinson CP, Yamamoto H, Peck A, Humphreys-Beher M. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: A potential trigger for sialoadenitis of NOD mice. Clin Immunol Immunopathol 1996; 79: 50-9.
102. Yamamoto H, Sims NE, MacAuley SP, Nguyen KH, Nakagawa Y, Humphreys-Beher MG. Alterations in the secretory response of non-obese diabetic (NOD) mice to muscarinic receptor stimulation. Clin Immunol Immunopathol 1996; 78: 245-55.
103. Hu Y, Purushotham KR, Wang P, Dawson R Jr, Humphreys-Beher MG. Downregulation of β-adrenergic receptors and signal transduction response in salivary glands of NOD mice. Am J Physiol 1994; 266: G433-43.
104. null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc Natl Acad Sci USA 1998; 95: 7538-43.
105. Bacman SR, Berra A, Sterin-Borda L, Borda ES. Human primary Sjögren's syndrome autoantibodies as mediators of nitric oxide release coupled to lacrimal gland muscarinic acetylcholine receptors. Curr Eye Res 1998; 17: 1135-42.
106. Konttinen YT, Platts LAM, Tuominen S, et al. Role of nitric oxide in Sjögren's syndrome. Arthritis Rheum 1997; 40: 875-83.
107. Nathan C, Xie Q-W. Nitric oxide synthases: Roles, tolls, controls. Cell 1994; 78: 915-8.
108. Wanchu A, Khullar M, Sud A, Bambery P. Elevated nitric oxide production in patients with primary Sjögren's syndrome. Clin Rheumatol 2000; 19: 360-4.
109. Thomsen LL, Lawton FG, Knowles RG, Beesley JE, Riveros-Moreno V, Moncada S. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994; 54: 1352-4.
110. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG, Moncada S. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995; 72: 41-4.
111. Sagar SM, Singh G, Hodson DI, Whitton AC. Nitric oxide and anticancer therapy. Cancer Treat Rev 1995; 21: 159-81.
112. Wink DA, Vodovotz Y, Laval D, Laval F, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998; 19: 711-21.
113. Brennan PA, Umar T, Buckley J, et al. Expression of nitric oxide synthase in pleomorphic adenomas of the parotid. Br J Oral Maxillofac Surg 2000; 38: 338-42.
114. Li LM, Kilbourn RG, Adams J, Fidler IJ. Role of nitric oxide in lysis of tumor cells by cytokine activated endothelial cells. Cancer Res 1991; 51: 2531-5.
115. Xie K, Huang S, Dong Z, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells. J Exp Med 1995; 181: 1333-43.
116. Bentz BG, Haines GK III, Hanson DG, Radosevich JA. Endothelial constitutive nitric oxide synthase (ecNOS) localization in normal and neoplastic salivary tissue. Head Neck 1998; 20: 304-9.
117. Rosbe KW, Prazma J, Petrusz P, Mims W, Ball SS, Weissler MC. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 1995; 113: 541-9.
118. Brennan PA, Palacios-Callender M, Sinclair D, Spedding AV, Zaki GA. Does expression of inducible nitric oxide synthase correlate with severity of oral epithelial dysplasia? J Craniomaxillofac Surg 2000; 28: 44-8.
119. Kendall HK, Haase HR, Li H, Xiao Y, Bartold PM. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodontal Res 2000; 35: 194-200.
120. Ohashi M, Iwase M, Nagumo M. Elevated production of salivary nitric oxide in oral mucosal diseases. J Oral Pathol Med 1999; 28: 355-9.
121. Brennan PA, Umar T, Palacios-Callender M, et al. A study to assess inducible nitric oxide synthase expression in oral lichen planus. J Oral Pathol Med 2000; 29: 249-54.
122. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991; 43: 109-42.
123. Änggård E. Nitric oxide: Mediator, murderer, and medicine. Lancet 1994; 343: 1199-206.
124. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995; 16: 128-30.
125. Spinas GA. The dual role of nitric oxide in islet β-cells. News Physiol Sci 1999; 14: 49-54.